Co-Authors
This is a "connection" page, showing publications co-authored by Gregg Fonarow and Clyde Yancy.
Connection Strength
8.847
-
Coronavirus Disease 2019 (COVID-19) and the Heart-Is Heart Failure the Next Chapter? JAMA Cardiol. 2020 11 01; 5(11):1216-1217.
Score: 0.911
-
Impediments to Implementing Guideline-Directed Medical Therapies. JAMA Cardiol. 2019 08 01; 4(8):830-831.
Score: 0.835
-
The New Hypertension Guidelines: Compelling Population Benefit, Manageable Risk, and Time to Implement. JAMA Cardiol. 2018 07 01; 3(7):581-582.
Score: 0.775
-
Consequences of Reductions in Hospital Readmissions. JAMA. 2017 11 21; 318(19):1933-1934.
Score: 0.743
-
The Hospital Readmission Reduction Program Is Associated With Fewer Readmissions, More Deaths: Time to Reconsider. J Am Coll Cardiol. 2017 10 10; 70(15):1931-1934.
Score: 0.737
-
Claims Data to Ascertain Clinical Events: Lost in Translation. JAMA Cardiol. 2017 07 01; 2(7):758.
Score: 0.723
-
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. 2020 07 01; 5(7):751-753.
Score: 0.223
-
Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2018 06 01; 3(6):489-497.
Score: 0.193
-
Medicare Expenditures by Race/Ethnicity After Hospitalization for Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2018 05; 6(5):388-397.
Score: 0.191
-
Evaluating Readmission-Need for More Clarity on Methods-Reply. JAMA Cardiol. 2018 03 01; 3(3):265-266.
Score: 0.189
-
A Hospital Level Analysis of 30-Day Readmission Performance for Heart Failure Patients and Long-Term Survival: Findings from Get With The Guidelines-Heart Failure. Am Heart J. 2018 06; 200:127-133.
Score: 0.187
-
Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure. JAMA Cardiol. 2018 01 01; 3(1):44-53.
Score: 0.187
-
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018 01 16; 71(2):201-230.
Score: 0.187
-
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. J Am Coll Cardiol. 2017 11 14; 70(20):2476-2486.
Score: 0.185
-
Incorporating Patient and Caregiver Experiences Into Cardiovascular Clinical Trial Design. JAMA Cardiol. 2017 11 01; 2(11):1263-1269.
Score: 0.185
-
Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail. 2017 07; 5(7):483-493.
Score: 0.179
-
Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy. JACC Heart Fail. 2017 05; 5(5):388-392.
Score: 0.179
-
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 08 08; 136(6):e137-e161.
Score: 0.179
-
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017 08 08; 70(6):776-803.
Score: 0.179
-
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017 08; 23(8):628-651.
Score: 0.179
-
Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. JAMA Cardiol. 2017 02 01; 2(2):136-145.
Score: 0.176
-
Lack of association between electronic health record systems and improvement in use of evidence-based heart failure therapies in outpatient cardiology practices. Clin Cardiol. 2012 Mar; 35(3):187-96.
Score: 0.124
-
Use and predictors of heart failure disease management referral in patients hospitalized with heart failure: insights from the Get With the Guidelines Program. J Card Fail. 2011 May; 17(5):431-9.
Score: 0.116
-
Characteristics of Acute Heart Failure Hospitalizations Based on Presenting Severity. Circ Heart Fail. 2019 01; 12(1):e005171.
Score: 0.050
-
Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes. Clin Cardiol. 2019 Feb; 42(2):256-263.
Score: 0.050
-
Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2018 10 01; 3(10):917-926.
Score: 0.049
-
Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. JACC Heart Fail. 2018 10; 6(10):844-855.
Score: 0.049
-
Association of the Affordable Care Act's Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure. Circ Cardiovasc Qual Outcomes. 2018 07; 11(7):e004729.
Score: 0.048
-
The Current Landscape of Atrial Fibrillation and Atrial Flutter Clinical Trials: A Report of 348 Studies Registered With ClinicalTrials.gov. JACC Clin Electrophysiol. 2018 07; 4(7):944-954.
Score: 0.048
-
Home-Time After Discharge Among Patients Hospitalized With Heart Failure. J Am Coll Cardiol. 2018 06 12; 71(23):2643-2652.
Score: 0.048
-
Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines-Heart Failure Registry. Circ Heart Fail. 2018 06; 11(6):e004646.
Score: 0.048
-
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2018 04 01; 3(4):288-297.
Score: 0.048
-
Timing of Postdischarge Follow-Up and Medication Adherence Among Patients With Heart Failure. J Am Heart Assoc. 2018 04 01; 7(7).
Score: 0.048
-
Early Ambulation Among Hospitalized Heart Failure Patients Is Associated With Reduced Length of Stay and 30-Day Readmissions. Circ Heart Fail. 2018 04; 11(4):e004634.
Score: 0.048
-
Association of Electronic Health Record Use With Quality of Care and Outcomes in Heart Failure: An Analysis of Get With The Guidelines-Heart Failure. J Am Heart Assoc. 2018 03 30; 7(7).
Score: 0.048
-
Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease. J Am Heart Assoc. 2017 12 23; 6(12).
Score: 0.047
-
Availability and Use of Shared Data From Cardiometabolic Clinical Trials. Circulation. 2018 02 27; 137(9):938-947.
Score: 0.046
-
Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure). Circulation. 2017 05 23; 135(21):2077-2080.
Score: 0.045
-
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2017 May 30; 135(22):e1054-e1091.
Score: 0.045
-
Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes. Am Heart J. 2017 Jul; 189:48-58.
Score: 0.044
-
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF). JACC Heart Fail. 2017 04; 5(4):305-309.
Score: 0.044
-
Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction. J Am Heart Assoc. 2017 02 11; 6(2).
Score: 0.044
-
Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Program". Circulation. 2017 01 17; 135(3):e22-e23.
Score: 0.044
-
2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2017 02 14; 69(6):712-744.
Score: 0.044
-
Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function. Am J Cardiol. 2017 03 15; 119(6):886-892.
Score: 0.044
-
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Jan 15; 61(2):213-65.
Score: 0.033
-
Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF). Am Heart J. 2009 Oct; 158(4):644-52.
Score: 0.026